ESR1 and triple-negative breast carcinoma: To further investigate the expression pattern of ESPL1 across various breast cancer (BC) subtypes, we utilized the bc-GenExMiner v5.0 database, stratifying the data based on estrogen receptor (ER), progesterone receptor (PR), and triple-negative breast cancer (TNBC) status.